These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25665792)

  • 1. Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway.
    Thuy le TT; Matsumoto Y; Thuy TT; Hai H; Suoh M; Urahara Y; Motoyama H; Fujii H; Tamori A; Kubo S; Takemura S; Morita T; Yoshizato K; Kawada N
    Am J Pathol; 2015 Apr; 185(4):1045-60. PubMed ID: 25665792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
    Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
    J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species.
    Dat NQ; Thuy LTT; Hieu VN; Hai H; Hoang DV; Thi Thanh Hai N; Thuy TTV; Komiya T; Rombouts K; Dong MP; Hanh NV; Hoang TH; Sato-Matsubara M; Daikoku A; Kadono C; Oikawa D; Yoshizato K; Tokunaga F; Pinzani M; Kawada N
    Hepatology; 2021 Jun; 73(6):2527-2545. PubMed ID: 33576020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism.
    Teranishi Y; Matsubara T; Krausz KW; Le TT; Gonzalez FJ; Yoshizato K; Ikeda K; Kawada N
    Lab Invest; 2015 May; 95(5):515-24. PubMed ID: 25686096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and expression pattern of cytoglobin in carbon tetrachloride-induced liver fibrosis.
    Man KN; Philipsen S; Tan-Un KC
    Toxicol Lett; 2008 Dec; 183(1-3):36-44. PubMed ID: 18940239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible Involvement of Nitric Oxide in Enhanced Liver Injury and Fibrogenesis during Cholestasis in Cytoglobin-deficient Mice.
    Van Thuy TT; Thuy LT; Yoshizato K; Kawada N
    Sci Rep; 2017 Feb; 7():41888. PubMed ID: 28157235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling.
    Sato-Matsubara M; Matsubara T; Daikoku A; Okina Y; Longato L; Rombouts K; Thuy LTT; Adachi J; Tomonaga T; Ikeda K; Yoshizato K; Pinzani M; Kawada N
    J Biol Chem; 2017 Nov; 292(46):18961-18972. PubMed ID: 28916723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice.
    Thi Thanh Hai N; Thuy LTT; Shiota A; Kadono C; Daikoku A; Hoang DV; Dat NQ; Sato-Matsubara M; Yoshizato K; Kawada N
    Sci Rep; 2018 Dec; 8(1):17860. PubMed ID: 30552362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.
    Nishizawa H; Iguchi G; Fukuoka H; Takahashi M; Suda K; Bando H; Matsumoto R; Yoshida K; Odake Y; Ogawa W; Takahashi Y
    Sci Rep; 2016 Oct; 6():34605. PubMed ID: 27721459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.
    Thuy LTT; Hai H; Kawada N
    Clin Mol Hepatol; 2020 Jul; 26(3):280-293. PubMed ID: 32492766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
    Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
    Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
    Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.